Aptevo Therapeutics : 09 January Investor Presentation

(marketscreener.com) 09 January 2023 Aptevo Therapeutics Clinical stage immunotherapy company developing cancer therapeutics NASDAQ: APVO Forward-Looking Statements Safe Harbor...https://www.marketscreener.com/quote/stock/APTEVO-THERAPEUTICS-INC-29774500/news/Aptevo-Therapeutics-09-January-Investor-Presentation-42692678/?utm_medium=RSS&utm_content=20230109